Fingerprint
Dive into the research topics of 'Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101
Antonius A. Miller, Daryl J. Murry, Kouros Owzar, Donna R. Hollis, Lionel D. Lewis, Hedy L. Kindler, John L. Marshall, Miguel A. Villalona-Calero, Martin J. Edelman, Raymond J. Hohl, Stuart M. Lichtman, Mark J. Ratain
Research output: Contribution to journal › Article › peer-review
71
Scopus
citations